Xu-Chen Cao (Xuchen Cao)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Topics

Bioinformatics Analysis

Transforming Growth Factor

Breast Cancer Risk

Top Venues

Journal of experimental & clinical cancer research : CR

Thoracic cancer

Journal of oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Bo-Wen Liu, Ning Sun, Hui Lin, Xue-Jie Zhou, Hai-Yan Ma, Xin Wang, Xu-Chen Cao, Yue Yu
The p53/ZEB1-PLD3 feedback loop regulates cell proliferation in breast cancer. Cell death & disease 14 (11) (2023)
Zhao-Hui Chen, Hao-Ran Yue, Jun-Hui Li, Ruo-Yu Jiang, Xiao-Ning Wang, Xue-Jie Zhou, Yue Yu, Xu-Chen Cao
HS3ST3A1 and CAPN8 Serve as Immune-Related Biomarkers for Predicting the Prognosis in Thyroid Cancer. Journal of oncology 2022 (2022)
Ao-Xiang Chen, Xiao Chen, Yue Yu, Xin Wang, Bin Zhang, Xu-Chen Cao
Immediate surgical mesh-free implant-based breast reconstruction with fascial flap in breast cancer patients after mastectomy. Archives of gynecology and obstetrics (2022)
Zhao-Hui Chen, Hao-Ran Yue, Jun-Hui Li, Ruo-Yu Jiang, Xiao-Ning Wang, Xue-Jie Zhou, Yue Yu, Xu-Chen Cao
HS3ST3A1 and CAPN8 Serve as Immune-Related Biomarkers for Predicting the Prognosis in Thyroid Cancer. Journal of oncology 2022 (2022)
Zheng-Jun Yang, Yu-Xiao Liu, Yue Huang, Zu-Jin Chen, Hao-Zhi Zhang, Yue Yu, Xin Wang, Xu-Chen Cao
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score. Cancer medicine (2022)
Zhi-Hao Yu, Zhao-Hui Chen, Guang-Lei Zhou, Xue-Jie Zhou, Hai-Yan Ma, Yue Yu, Xin Wang, Xu-Chen Cao
miR-92a-3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis. Thoracic cancer 13 (21) (2022)
Li-Xiang Yu, Li-Yuan Liu, Yu-Juan Xiang, Fei Wang, Fei Zhou, Shu-Ya Huang, Chao Zheng, Chun-Miao Ye, Wen-Zhong Zhou, Geng-Shen Yin, Jia-Lin Zhang, Shu-De Cui, Fu-Guo Tian, Zhi-Min Fan, Cui-Zhi Geng, Xu-Chen Cao, Zhen-Lin Yang, Xiang Wang, Hong Liang, Shu Wang, Hong-Chuan Jiang, Xue-Ning Duan, Hai-Bo Wang, Guo-Lou Li, Qi-Tang Wang, Jian-Guo Zhang, Feng Jin, Jin-Hai Tang, Liang Li, Shi-Guang Zhu, Wen-Shu Zuo, Zhong-Bing Ma, Zhi-Gang Yu
XRCC5/6 polymorphisms and their interactions with smoking, alcohol consumption, and sleep satisfaction in breast cancer risk: A Chinese multi-center study. Cancer medicine 10 (8) (2021)
Jing Jiang, Hui Lin, Shenghong Shi, Ying Hong, Xianan Bai, Xu-Chen Cao
Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis. Thoracic cancer 11 (11) (2020)
Yue Yu, Xu-Chen Cao
miR-190-5p in human diseases. Cancer cell international 19 (2019)
Jiao Zhang, Yan-Jun Zhou, Zhi-Hao Yu, Ao-Xiang Chen, Yue Yu, Xin Wang, Xu-Chen Cao
Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets. Bioscience reports 39 (6) (2019)
Bo-Wen Liu, Zhi-Hao Yu, Ao-Xiang Chen, Jiang-Rui Chi, Jie Ge, Yue Yu, Xu-Chen Cao
Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression. Journal of experimental & clinical cancer research : CR 38 (1) (2019)
Yue Yu, Wen Yin, Zhi-Hao Yu, Yan-Jun Zhou, Jiang-Rui Chi, Jie Ge, Xu-Chen Cao
miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer. Journal of experimental & clinical cancer research : CR 38 (1) (2019)
Zheng-Jun Yang, Yue Yu, Jiang-Rui Chi, Meng Guan, Ying Zhao, Xu-Chen Cao
The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual. Breast cancer (Tokyo, Japan) 25 (3) (2018)
Yue Yu, Wei Luo, Zheng-Jun Yang, Jiang-Rui Chi, Yun-Rui Li, Yu Ding, Jie Ge, Xin Wang, Xu-Chen Cao
miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition. Molecular cancer 17 (1) (2018)
Jie Ge, Yue Yu, Fei Xin, Zheng-Jun Yang, Hong-Meng Zhao, Xin Wang, Zhong-Sheng Tong, Xu-Chen Cao
Downregulation of delta-aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer. Cancer science 108 (4) (2017)